TRVI Trevi Therapeutics, Inc.
Nasdaq · SEC CIK 1563880 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $595.8K 1 sales by 1 insiders
- Filings on record
- 131 since 2021-08-09, latest 2026-09-17 16:55
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Heffernan Michael Thomas | Dir | — | $595.8K |
| Galletta Christopher | See Remarks | — | — |
Transactions 72
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-17 16:55 | 2026-09-15 | TRVI | Heffernan Michael Thomas | Dir | M - OptEx | $3.19 | +39.5K | 27.4K | New | +$126.1K |
| DMT | 2026-09-17 16:55 | 2026-09-15 | TRVI | Heffernan Michael Thomas | Dir | S - Sale+OE | $15.09 | -39.5K | 6,351 | -86% | -$595.8K |
| D | 2025-12-03 | 2025-12-02 | TRVI | Galletta Christopher | See Remarks | M - OptEx | $0.51 | +4,225 | 26.1K | +19% | +$2,155 |
| D | 2025-03-26 | 2025-03-25 | TRVI | SCIASCIA THOMAS | CSO | S - Sale+OE | $6.60 | -2,631 | 221.4K | -1% | -$17.4K |
| D | 2025-03-26 | 2025-03-25 | TRVI | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +2,631 | 224.0K | +1% | +$3,762 |
| D | 2025-03-25 | 2025-03-21 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $1.43 | +5,263 | 218.6K | +2% | +$7,526 |
| D | 2025-03-25 | 2025-03-21 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | S - Sale+OE | $6.58 | -5,263 | 213.3K | -2% | -$34.6K |
| DMT | 2025-03-12 | 2025-03-10 | TRVI | Simon Farrell | Chief Commercial Off | S - Sale+OE | $6.75 | -81.3K | 81.2K | -50% | -$549.1K |
| DMT | 2025-03-12 | 2025-03-10 | TRVI | Simon Farrell | Chief Commercial Off | M - OptEx | $2.86 | +112.6K | 63.1K | New | +$321.6K |
| DM | 2025-01-10 | 2025-01-07+ | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +6,000 | 59.7K | +11% | +$3,060 |
| D | 2024-12-17 | 2024-12-13 | TRVI | Galletta Christopher | See Remarks | M - OptEx | $0.51 | +15.0K | 19.9K | +304% | +$7,650 |
| DM | 2024-09-09 | 2024-09-06+ | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $1.43 | +6,059 | 215.2K | +3% | +$8,664 |
| DM | 2024-09-09 | 2024-09-06+ | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | S - Sale+OE | $3.03 | -6,059 | 213.3K | -3% | -$18.4K |
| DM | 2024-09-05 | 2024-09-03+ | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | S - Sale+OE | $3.09 | -55.1K | 213.3K | -21% | -$170.1K |
| DM | 2024-09-05 | 2024-09-03+ | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $1.43 | +55.1K | 217.2K | +34% | +$78.8K |
| D | 2024-08-29 | 2024-08-27 | TRVI | Meeker David P | Dir | M - OptEx | $1.43 | +4,555 | 357.0K | +1% | +$6,514 |
| D | 2024-08-29 | 2024-08-27 | TRVI | Meeker David P | Dir | S - Sale+OE | $2.93 | -4,555 | 352.5K | -1% | -$13.3K |
| D | 2024-08-21 | 2024-08-19 | TRVI | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +16.5K | 236.8K | +7% | +$23.6K |
| D | 2024-08-21 | 2024-08-19 | TRVI | SCIASCIA THOMAS | CSO | S - Sale+OE | $2.96 | -16.5K | 220.3K | -7% | -$48.8K |
| DM | 2024-08-16 | 2024-08-14+ | TRVI | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +31.5K | 220.4K | +17% | +$45.1K |
| DM | 2024-08-16 | 2024-08-14+ | TRVI | SCIASCIA THOMAS | CSO | S - Sale+OE | $2.77 | -31.5K | 220.3K | -13% | -$87.3K |
| D | 2024-05-31 | 2024-05-29 | TRVI | SCIASCIA THOMAS | CSO | S - Sale+OE | $2.55 | -53.4K | 214.4K | -20% | -$136.1K |
| D | 2024-05-31 | 2024-05-29 | TRVI | SCIASCIA THOMAS | CSO | M - OptEx | $2.19 | +59.4K | 267.8K | +28% | +$130.0K |
| D | 2024-05-24 | 2024-05-22 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +16.0K | 57.6K | +39% | +$8,182 |
| D | 2024-05-24 | 2024-05-22 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.64 | -4,350 | 53.3K | -8% | -$11.5K |
| D | 2024-05-22 | 2024-05-20 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $2.19 | +25.0K | 238.3K | +12% | +$54.8K |
| D | 2024-05-22 | 2024-05-20 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | S - Sale+OE | $2.86 | -25.0K | 213.3K | -11% | -$71.6K |
| D | 2024-05-14 | 2024-05-10 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | S - Sale+OE | $2.90 | -4,578 | 213.3K | -2% | -$13.3K |
| D | 2024-05-14 | 2024-05-10 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $2.19 | +4,578 | 217.9K | +2% | +$10.0K |
| D | 2023-10-12 | 2023-10-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.02 | -785 | 35.9K | -2% | -$1,586 |
| D | 2023-10-12 | 2023-10-11 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,292 | 36.7K | +7% | +$1,169 |
| D | 2023-09-13 | 2023-09-11 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,291 | 35.1K | +7% | +$1,168 |
| D | 2023-09-13 | 2023-09-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.20 | -711 | 34.4K | -2% | -$1,564 |
| D | 2023-08-14 | 2023-08-11 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,292 | 33.5K | +7% | +$1,169 |
| D | 2023-08-14 | 2023-08-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.36 | -682 | 32.8K | -2% | -$1,610 |
| D | 2023-07-12 | 2023-07-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.34 | -687 | 31.2K | -2% | -$1,608 |
| D | 2023-07-12 | 2023-07-11 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,292 | 31.9K | +8% | +$1,169 |
| D | 2023-06-21 | 2023-06-20 | TRVI | Simon Farrell | Chief Commercial Off | M - OptEx | $0.51 | +6,250 | 45.6K | +16% | +$3,188 |
| D | 2023-06-14 | 2023-06-12 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,291 | 30.2K | +8% | +$1,168 |
| D | 2023-06-14 | 2023-06-12 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.64 | -610 | 29.6K | -2% | -$1,610 |
| D | 2023-05-15 | 2023-05-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.89 | -562 | 27.9K | -2% | -$1,624 |
| D | 2023-05-15 | 2023-05-11 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,291 | 28.5K | +9% | +$1,168 |
| D | 2023-04-12 | 2023-04-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $1.84 | -840 | 26.2K | -3% | -$1,546 |
| D | 2023-04-12 | 2023-04-11 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,292 | 27.0K | +9% | +$1,169 |
| D | 2023-03-15 | 2023-03-13 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +2,291 | 25.6K | +10% | +$1,168 |
| D | 2023-03-15 | 2023-03-13 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $1.75 | -892 | 24.7K | -3% | -$1,561 |
| D | 2023-03-08 | 2023-03-07 | TRVI | Simon Farrell | Chief Commercial Off | M - OptEx | $0.51 | +18.8K | 39.4K | +91% | +$9,562 |
| D | 2023-02-15 | 2023-02-13 | TRVI | Delfini Lisa | CFO | M - OptEx | $0.51 | +27.5K | 31.8K | +638% | +$14.0K |
| D | 2023-02-15 | 2023-02-13 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.45 | -8,474 | 23.3K | -27% | -$20.8K |
| MI | 2022-07-06 | 2022-07-01+ | TRVI | WINKELRIED JON | Former 10% Owner | S - Sale | $2.89 | -500.0K | 3.82M | -12% | -$1.45M |
| MI | 2022-07-01 | 2022-06-29+ | TRVI | WINKELRIED JON | 10% | S - Sale | $2.77 | -476.0K | 4.75M | -9% | -$1.32M |
| I | 2022-05-04 | 2022-05-02 | TRVI | COULTER JAMES G | 10% | S - Sale | $2.70 | -600 | 4.80M | -0.0% | -$1,620 |
| MI | 2022-05-02 | 2022-04-28+ | TRVI | COULTER JAMES G | 10% | S - Sale | $2.76 | -23.4K | 4.80M | -0.5% | -$64.6K |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | SANDELL SCOTT D | 10% | P - Purchase | $1.90 | +3.58M | 948.9K | New | +$6.80M |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | Sonsini Peter W. | 10% | P - Purchase | $1.90 | +3.58M | 10.42M | +52% | +$6.80M |
| 2022-04-13 | 2022-04-11 | TRVI | NEA 16 GP, LLC | 10% | P - Purchase | $1.90 | +2.63M | 10.42M | +34% | +$5.00M | |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | Chang Carmen | 10% | P - Purchase | $1.90 | +3.58M | 10.42M | +52% | +$6.80M |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | Makhzoumi Mohamad | 10% | P - Purchase | $1.90 | +3.58M | 948.9K | New | +$6.80M |
| DI | 2022-04-13 | 2022-04-11 | TRVI | Mathers Edward T | Dir | A - Grant | $1.90 | +948.9K | 948.9K | New | +$1.80M |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | Florence Anthony A. Jr. | 10% | P - Purchase | $1.90 | +3.58M | 948.9K | New | +$6.80M |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | Walker Paul Edward | 10% | P - Purchase | $1.90 | +3.58M | 10.42M | +52% | +$6.80M |
| DMI | 2022-04-13 | 2022-04-11 | TRVI | Behbahani Ali | 10% | P - Purchase | $1.90 | +3.58M | 948.9K | New | +$6.80M |
| I | 2022-04-13 | 2022-04-11 | TRVI | BASKETT FOREST | 10% | P - Purchase | $1.90 | +2.63M | 10.42M | +34% | +$5.00M |
| DI | 2021-10-19 | 2021-10-18 | TRVI | Florence Anthony A. Jr. | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | Chang Carmen | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | Walker Paul Edward | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | SANDELL SCOTT D | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | BASKETT FOREST | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | Sonsini Peter W. | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| D | 2021-10-19 | 2021-10-18 | TRVI | NEA Partners 16, L.P. | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | Makhzoumi Mohamad | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
| DI | 2021-10-19 | 2021-10-18 | TRVI | Behbahani Ali | 10% | P - Purchase | — | +1.85M | 7.79M | +31% | — |
Purchase Sale Sale after option exercise All abbreviations